Skip to main content

Promedius Inc.

PROMEDIUS develops AI software to support healthy aging by analyzing medical imaging data. Their Osteo Signal product provides osteoporosis diagnosis support using chest X-rays, while Myo Signal offers muscle and fat segmentation from abdominal CT scans. This technology aims to improve diagnostic workflows and early detection for age-related conditions.

Traction 7/10
Seoul, South Korea · HQ
Founded 2019251K+ followers
  • Artificial Intelligence
  • Digital Health
  • Healthcare Technology
  • Software Only
Updated 6 months ago

Funding

Raised to date

$20.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

$8.5M across 1 disclosed round

CVDIKISIWV

$8.5M · Series A

Announced Mar 2024

Disclosed cumulative: $8.5M

Reported total $20.6M

Incomplete round history. $12.1M of the $20.6M reported total isn’t matched to a known round.

Founders

1 founder

Hyun-Jin Bae

Co-Founder & CIO

Product

Features

  • PROMEDIUS develops AI software to support healthy aging by analyzing medical imaging data. Their Osteo Signal product provides osteoporosis diagnosis support using chest X-rays, while Myo Signal offers muscle and fat segmentation from abdominal CT scans. This technology aims to improve diagnostic workflows and early detection for age-related conditions.
This profile is AI-generated and may contain inaccuracies.